Skip to main content

Table 3 Factors associated with anemia in HIV-infected patients on second line ART at two urban HIV clinics in Lilongwe, Malawi

From: Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study

 

Unadjusted Odds Ratios

Adjusted Odds Ratios

Characteristic

(95% CI)

p-value

(95% CI)

p-value

Sex

    

 Male

1

 

1

1

 Female

4.1 (2.5–7.0)

<0.001

5.3 (2.9–9.5)

<0.001

Age

    

 ≤29

1

   

 30–39

1.4 (0.6–3.2)

0.39

  

 40–49

0.9 (0.4–1.9)

0.69

  

 ≥50

0.6 (0.3–1.5)

0.30

  

Total time on ART (years)

    

 0–5

1

 

1

1

 6–10

1.2 (0.7–2.0)

0.60

  

 11–15

0.4 (0.2–0.8)

0.02

0.4 (0.2–0.9)

0.02

Second line ART regimen

    

 contains AZT

1

   

 does not contain AZT

1.3 (0.7–2.4)

0.36

  

CD4 cell count

    

 ≥500

1

 

1

1

 350–499

0.8 (0.5–1.6)

0.67

  

 200–349

0.8 (0.4–1.5)

0.47

  

 <200

2.4 (1.3–4.4)

0.01

3.1(1.6–6.0)

0.001

Viral load

    

 <=1000

1

   

 >1000

1.3 (0.6–2.7)

0.49

  

Body mass index

    

 <18.5

1.5 (0.7–3.5)

0.33

  

 18.5–24.9

1

 

1

1

 25–29.9

1.0 (0.6–1.8)

0.86

  

 ≥30

0.6 (0.3–1.1)

0.08

0.8 (0.6–1.0)

0.02

Glomerular filtration rate

    

 >90

1

   

 30–89

0.7 (0.5–1.1)

0.15

  

 <30

9.0 (1–78.4)

0.047

  
  1. CI-confidence intervals
  2. AZT- zidovudine